BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35615018)

  • 1. Structural bioinformatics enhances the interpretation of somatic mutations in KDM6A found in human cancers.
    Chi YI; Stodola TJ; De Assuncao TM; Leverence EN; Smith BC; Volkman BF; Mathison AJ; Lomberk G; Zimmermann MT; Urrutia R
    Comput Struct Biotechnol J; 2022; 20():2200-2211. PubMed ID: 35615018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanics and dynamic simulations of well-known Kabuki syndrome-associated KDM6A variants reveal putative mechanisms of dysfunction.
    Chi YI; Stodola TJ; De Assuncao TM; Leverence EN; Tripathi S; Dsouza NR; Mathison AJ; Basel DG; Volkman BF; Smith BC; Lomberk G; Zimmermann MT; Urrutia R
    Orphanet J Rare Dis; 2021 Feb; 16(1):66. PubMed ID: 33546721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-layered computational structural genomics approach enhances domain-specific interpretation of Kleefstra syndrome variants in EHMT1.
    Chi YI; Jorge SD; Jensen DR; Smith BC; Volkman BF; Mathison AJ; Lomberk G; Zimmermann MT; Urrutia R
    Comput Struct Biotechnol J; 2023; 21():5249-5258. PubMed ID: 37954151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multi-Layered Computational Structural Genomics Approach Enhances Domain-Specific Interpretation of Kleefstra Syndrome Variants in EHMT1.
    Chi YI; Jorge SD; Jensen DR; Smith BC; Volkman BF; Mathison AJ; Lomberk G; Zimmermann MT; Urrutia R
    bioRxiv; 2023 Sep; ():. PubMed ID: 37786696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of VUS and unclassified variants in
    Sinha S; Wang SM
    Comput Struct Biotechnol J; 2020; 18():723-736. PubMed ID: 32257056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine Demethylase KDM6A in Differentiation, Development, and Cancer.
    Tran N; Broun A; Ge K
    Mol Cell Biol; 2020 Sep; 40(20):. PubMed ID: 32817139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep computational phenotyping of genomic variants impacting the SET domain of KMT2C reveal molecular mechanisms for their dysfunction.
    Jorge SD; Chi YI; Mazaba JL; Haque N; Wagenknecht J; Smith BC; Volkman BF; Mathison AJ; Lomberk G; Zimmermann MT; Urrutia R
    Front Genet; 2023; 14():1291307. PubMed ID: 38090150
    [No Abstract]   [Full Text] [Related]  

  • 8. KDM6A mutations promote acute cytoplasmic DNA release, DNA damage response and mitosis defects.
    Koch J; Lang A; Whongsiri P; Schulz WA; Hoffmann MJ; Greife A
    BMC Mol Cell Biol; 2021 Oct; 22(1):54. PubMed ID: 34702163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of lysine-specific demethylase 6A (KDM6A) in tumorigenesis and its therapeutic potentials in cancer therapy.
    Chen LJ; Xu XY; Zhong XD; Liu YJ; Zhu MH; Tao F; Li CY; She QS; Yang GJ; Chen J
    Bioorg Chem; 2023 Apr; 133():106409. PubMed ID: 36753963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of KMT2D and KDM6A variants by targeted sequencing from patients with Kabuki syndrome and other congenital disorders.
    Yap CS; Jamuar SS; Lai AHM; Tan ES; Ng I; Ting TW; Tan EC
    Gene; 2020 Mar; 731():144360. PubMed ID: 31935506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KDM6A missense variants hamper H3 histone demethylation in lung squamous cell carcinoma.
    Biagini T; Petrizzelli F; Bianco SD; Liorni N; Napoli A; Castellana S; Luigi Vescovi A; Carella M; Caputo V; Mazza T
    Comput Struct Biotechnol J; 2022; 20():3151-3160. PubMed ID: 35782738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural dynamics of clinically-reported VUS in the BARD1 ARD-BRCT region to predict the molecular basis of alterations.
    Barua SA; Choudhary RK; Gawde J; Mishra N; Varma AK
    J Biomol Struct Dyn; 2024 Jul; 42(11):5475-5484. PubMed ID: 37418175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the Oro-Dental and Mutational Spectra of Kabuki Syndrome and Expression of
    Porntaveetus T; Abid MF; Theerapanon T; Srichomthong C; Ohazama A; Kawasaki K; Kawasaki M; Suphapeetiporn K; Sharpe PT; Shotelersuk V
    Int J Biol Sci; 2018; 14(4):381-389. PubMed ID: 29725259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
    Chang S; Yim S; Park H
    Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational analysis of deleterious single nucleotide polymorphisms in catechol O-Methyltransferase conferring risk to post-traumatic stress disorder.
    Chitrala KN; Nagarkatti P; Nagarkatti M
    J Psychiatr Res; 2021 Jun; 138():207-218. PubMed ID: 33865170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent alterations in TERT, KDM6A, and the BRCA pathway in bladder cancer.
    Nickerson ML; Dancik GM; Im KM; Edwards MG; Turan S; Brown J; Ruiz-Rodriguez C; Owens C; Costello JC; Guo G; Tsang SX; Li Y; Zhou Q; Cai Z; Moore LE; Lucia MS; Dean M; Theodorescu D
    Clin Cancer Res; 2014 Sep; 20(18):4935-48. PubMed ID: 25225064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo exonic deletion of KDM6A in a Chinese girl with Kabuki syndrome: A case report and brief literature review.
    Yang P; Tan H; Xia Y; Yu Q; Wei X; Guo R; Peng Y; Chen C; Li H; Mei L; Huang Y; Liang D; Wu L
    Am J Med Genet A; 2016 Jun; 170(6):1613-21. PubMed ID: 27028180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of KDM6A mutation in bladder cancer immune escape.
    Chen X; Lin X; Pang G; Deng J; Xie Q; Zhang Z
    BMC Cancer; 2021 May; 21(1):635. PubMed ID: 34051747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility.
    Lee SW; Park DY; Kim MY; Kang C
    Gastric Cancer; 2019 May; 22(3):640-644. PubMed ID: 30374835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLL2 and KDM6A mutations in patients with Kabuki syndrome.
    Miyake N; Koshimizu E; Okamoto N; Mizuno S; Ogata T; Nagai T; Kosho T; Ohashi H; Kato M; Sasaki G; Mabe H; Watanabe Y; Yoshino M; Matsuishi T; Takanashi J; Shotelersuk V; Tekin M; Ochi N; Kubota M; Ito N; Ihara K; Hara T; Tonoki H; Ohta T; Saito K; Matsuo M; Urano M; Enokizono T; Sato A; Tanaka H; Ogawa A; Fujita T; Hiraki Y; Kitanaka S; Matsubara Y; Makita T; Taguri M; Nakashima M; Tsurusaki Y; Saitsu H; Yoshiura K; Matsumoto N; Niikawa N
    Am J Med Genet A; 2013 Sep; 161A(9):2234-43. PubMed ID: 23913813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.